−239.73 MUSD
1.80 MUSD
About Inhibrx Biosciences, Inc.
Sector
Industry
CEO
Mark Paul Lappe
Website
Headquarters
La Jolla
Founded
2024
FIGI
BBG01MS5Q9G3
Inhibrx Biosciences, Inc. operates as an American clinical-stage biotechnology company for biologic therapeutic candidates. The private company is based in DE.
Short/Long $INBX Trade IdeaAs we can see $INBX "ping pong" between is "R"=resistance and "S" =support levels
Im the case he break is support we got a high chances he will retrace to close his gap or a t least check the gap horizontal support line there is no structure in the way down but recent candela from the prior month
$INBX is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Inhibrx is advancing a pipeline of candidates for the treatment of various rare cancers and AATD.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of INBX is 16.59 USD — it has decreased by 0.36% in the past 24 hours. Watch Inhibrx Biosciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Inhibrx Biosciences, Inc. stocks are traded under the ticker INBX.
INBX stock has risen by 0.55% compared to the previous week, the month change is a 52.05% fall, over the last year Inhibrx Biosciences, Inc. has showed a 32.97% decrease.
INBX reached its all-time high on Dec 18, 2020 with the price of 50.97 USD, and its all-time low was 7.67 USD and was reached on Jun 16, 2022. View more price dynamics on INBX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Today Inhibrx Biosciences, Inc. has the market capitalization of 241.02 M, it has decreased by 0.23% over the last week.
Yes, you can track Inhibrx Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
INBX net income for the last quarter is −78.71 M USD, while the quarter before that showed −48.92 M USD of net income which accounts for −60.91% change. Track more Inhibrx Biosciences, Inc. financial stats to get the full picture.
No, INBX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, INBX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Inhibrx Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Inhibrx Biosciences, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Inhibrx Biosciences, Inc. stock shows the strong sell signal. See more of Inhibrx Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.